Method for Diagnostics, Treatment and Prevention of Parkinson's Disease
Abstract
The present invention relates to the field of medicine and in particular to Parkinson's disease (PD). Specifically the present invention relates to methods and means for early detection of PD. The invention relates also to methods and means for treatment or prophylaxis of PD. In the method of the invention a probability of a subject developing or having Parkinson's disease (PD) is determined by measuring the relative abundances of one or multiple microbial taxa in a sample from a subject; and the probability of the subject developing or having PD is determined based on the measured abundances. The present invention provides a novel approach for the diagnostics of PD.
Claims
exact text as granted — not AI-modified1 .- 13 . (canceled)
14 . A composition for use in treatment or prevention of Parkinson's disease (PD) in an individual, wherein the composition increases abundance of intestinal Prevotellaceae in said individual.
15 . The composition of claim 14 , wherein the composition comprises live or killed microbes and optionally a pharmaceutically acceptable carrier.
16 . The composition of claim 14 , wherein the composition comprises live or killed microbes and a pharmaceutically acceptable carrier.
17 . The composition of claim 14 , wherein the composition comprises one or more members selected from the group consisting of probiotics, other micro-organisms, prebiotics, antibiotics, growth factors, and bacteriophages.
18 . The composition of claim 14 wherein the composition comprises Prevotellaceae.
19 . The composition of claim 14 , wherein the composition decreases intestinal abundance of one or more of taxa selected from the group consisting of Lactobacillaceae, Verrucomicrobiaceae, Bradyrhizobiaceae, Clostridiales Incertae Sedis IV, Ruminococcaceae, Lachnospiraceae, Enterobacteriaceae, Bacteroidaceae, Alistipes, Coprococcus, Anaerotruncus , Porphyromonadaceae, Parabacteroides, Butyricicoccus, Collinsella, Eggerthella , Coriobacteriaceae, Sporobacterium, Actinobacteria, Blautia, Enterococcus, Acetivibrio, Allobaculum Agromonas, Firmicutes, Mahella, Phaeovibrio , Porphyromonadaceae, Oscillibacter , and Saccharofermentans.
20 . The composition of claim 14 , wherein the composition is in the form of a food composition, pharmaceutical composition, nutraceutical, supplement or an anaerobical microbiota culture.
21 . A method for treatment or prevention of Parkinson's disease (P D) in an individual comprising administering to said individual a composition that increases the abundance of intestinal Prevotellaceae in said individual when administered to said individual.
22 . The method of claim 21 , wherein the composition comprises live or killed microbes and optionally a pharmaceutically acceptable carrier.
23 . The method of claim 21 , wherein the composition comprises one or more members selected from the group consisting of probiotics, other micro-organisms, prebiotics, antibiotics, growth factors, and bacteriophages.
24 . The method of claim 21 , wherein the composition comprises Prevotellaceae.
25 . The method of claim 21 , wherein the composition is a stool transplant.
26 . The method of claim 25 , wherein a donor of the stool transplant is selected based on high abundance of Prevotellaceae and/or low abundance of one or more of taxa selected from the group consisting of Enterobacteriaceae, Lactobacillaceae, Ruminococcaceae, Bacteroidaceae, Lachnospiraceae, Verrucomicrobiaceae, Bradyrhizobiaceae, Clostridiales Incertae Sedis IV, Alistipes, Coprococcus, Anaerotruncus , Porphyromonadaceae, Parabacteroides, Butyricicoccus, Collinsella, Eggerthella , Coriobacteriaceae, Sporobacterium, Actinobacteria, Blautia, Enterococcus, Acetivibrio, Allobaculum Agromonas, Firmicutes, Mahella, Phaeovibrio , Porphyromonadaceae, Oscillibacter , and Saccharofermentans.Join the waitlist — get patent alerts
Track US2019137493A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.